Abstract:Nitric oxide (NO) and reactive nitrogen species (RNS) exert profound biological impacts dictated by their chemistry. Understanding their spatial distribution is essential for deciphering their roles in diverse biological processes. This review establishes a framework for the chemical biology of NO and RNS, exploring their dynamic reactions within the context of cancer. Concentration-dependent signaling reveals distinctive processes in cancer, with three levels of NO influencing oncogenic properties. In this context, NO plays a crucial role in cancer cell proliferation, metastasis, chemotherapy resistance, and immune suppression. Increased NOS2 expression correlates with poor survival across different tumors, including breast cancer. Additionally, NOS2 can crosstalk with the proinflammatory enzyme cyclooxygenase-2 (COX-2) to promote cancer progression. NOS2 and COX-2 co-expression establishes a positive feed-forward loop, driving immunosuppression and metastasis in estrogen receptor-negative (ER-) breast cancer. Spatial evaluation of NOS2 and COX-2 reveals orthogonal expression, suggesting the unique roles of these niches in the tumor microenvironment (TME). NOS2 and COX2 niche formation requires IFN-γ and cytokine-releasing cells. These niches contribute to poor clinical outcomes, emphasizing their role in cancer progression. Strategies to target these markers include direct inhibition, involving pan-inhibitors and selective inhibitors, as well as indirect approaches targeting their induction or downstream effectors. Compounds from cruciferous vegetables are potential candidates for NOS2 and COX-2 inhibition offering therapeutic applications. Thus, understanding the chemical biology of NO and RNS, their spatial distribution, and their implications in cancer progression provides valuable insights for developing targeted therapies and preventive strategies.

Nitroxyl As a Potential Theranostic in the Cancer Arena.

Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects.

Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer

Nitric Oxide Donor Hybrid Compounds As Promising Anticancer Agents

Recent advances in diverse nanosystems for nitric oxide delivery in cancer therapy

The Emerging Roles of Nitric Oxide in Ferroptosis and Pyroptosis of Tumor Cells.

Advances in Research of Nitric Oxide-Donor Drugs As Anticancer Agents

Research Advances on Tumor Therapy via Nitric Oxide

Regulation of pleiotropic physiological roles of nitric oxide signaling

A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer

Stimuli Responsive Nitric Oxide-Based Nanomedicine for Synergistic Therapy

Nitric Oxide, Coagulation and Cancer

The Application of Nitric Oxide Delivery in Nanoparticle-Based Tumor Targeting Drug Delivery and Treatment

The role of nitric oxide synthase/ nitric oxide in infection-related cancers: Beyond antimicrobial activity

Nitric Oxide and S-Nitrosylation in Cancers: Emphasis on Breast Cancer

Photogenerated Holes Mediated Nitric Oxide Production for Hypoxic Tumor Treatment

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer.

Advanced Nitric Oxide Generating Nanomedicine for Therapeutic Applications

Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology

Protein Phosphorylation in Cancer: Role of Nitric Oxide Signaling Pathway

Stimuli‐Responsive NO Release for On‐Demand Gas‐Sensitized Synergistic Cancer Therapy